BTLA antibodies and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9896507
APP PUB NO 20150147344A1
SERIAL NO

14550429

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to BTLA antibodies that block BTLA-HVEM interaction and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)PARIS FRANCE PARIS PARIS
UNIVERSITE D'AIX MARSEILLE58 BOULEVARD CHARLES LIVON MARSEILLE CEDEX 07 13284
INSTITUT JEAN PAOLI & IRENE CALMETTES232 BOULEVARD SAINTE-MARGUERITE MARSEILLE 13009

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gondois-Rey, Francoise Marseilles, FR 2 0
Olive, Daniel Marseilles, FR 52 375
Pastor, Sonia Marseilles, FR 2 0
Serriari, Nacer-Eddine Amiens, FR 3 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00